Switch to:
More From Other Websites
Ultragenyx Receives Priority Review for rhGUS from FDA May 24 2017
Why Sangamo Therapeutics Inc. Jumped Higher Today May 12 2017
Biotech Stock Roundup: Regeneron, BioMarin Report Q1, Kite Down on Patient Death May 10 2017
BioMarin Pharmaceutical Inc. Moves Toward Profitability May 09 2017
Edited Transcript of BMRN earnings conference call or presentation 4-May-17 8:30pm GMT May 09 2017
BioMarin Pharmaceutical, Inc. breached its 50 day moving average in a Bearish Manner : BMRN-US : May... May 09 2017
BioMarin: Is Profitability On The Horizon? May 08 2017
These Biotechs Are Grabbing Bullish Views In Wake Of Earnings May 05 2017
BioMarin (BMRN) Posts Earnings in Q1, Sales Top, Stock Up May 05 2017
BioMarin reports 1Q loss May 04 2017
BioMarin Announces First Quarter 2017 Financial Results May 04 2017
Investor Network: BioMarin Pharmaceutical Inc. to Host Earnings Call May 04 2017
[$$] Did Gilead Cut Buybacks for Acquisition? May 04 2017
Why Earnings Season Could Be Great for BioMarin (BMRN) May 03 2017
BioMarin to Attend Two Upcoming Investor Conferences May 02 2017
BioMarin CEO says 'the system will have to determine' the... Apr 28 2017
BioMarin CEO says 'the system will have to determine' the worth of its new $702,000 drug Apr 28 2017
Today's Research Reports on Biotech Stocks to Watch: Pacific Biosciences of California and BioMarin... Apr 28 2017
BioMarin wins FDA approval for life-changing drug for kids — with a $700,000-per-year cost Apr 27 2017
BioMarin Prices Orphan Drug at $702,000, Promises Big Discounts Apr 27 2017


No Entry for this criteria! We are updating our databases daily, please come back later!

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK